JOSEPH JANKOVIC to Monoamine Oxidase Inhibitors
This is a "connection" page, showing publications JOSEPH JANKOVIC has written about Monoamine Oxidase Inhibitors.
Connection Strength
0.129
-
A double-blind, delayed-start trial of rasagiline in Parkinson's disease. N Engl J Med. 2009 Sep 24; 361(13):1268-78.
Score: 0.083
-
Parkinson's disease therapy: treatment of early and late disease. Chin Med J (Engl). 2001 Mar; 114(3):227-34.
Score: 0.046